npj Precision Oncology

npj Precision Oncology banner

Potential utility of risk stratification for multicancer screening with liquid biopsy tests

Elle S. Kim
Robert B. Scharpf
Nilanjan Chatterjee

Brief Communication 22 April 2023

Featured

Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature

Jessica A. Scarborough
Steven A. Eschrich
Jacob G. Scott
ArticleOpen Access19 Apr 2023
Self-supervised attention-based deep learning for pan-cancer mutation prediction from histopathology

Oliver Lester Saldanha
Chiara M. L. Loeffler
Jakob Nikolas Kather
Brief CommunicationOpen Access28 Mar 2023
Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge

Fergus Keane
Raazi Bajwa
Eileen M. O’Reilly
Case ReportOpen Access22 Apr 2023
Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies

Omar Alhalabi
Roman Groisberg
Vivek Subbiah
ProtocolOpen Access18 Apr 2023

Announcements

Submit to our new Collection: AI in Precision Oncology

Deadline: 19 October 2023

Open for submissions
npj Precision Oncology Journal Metrics

npj Precision Oncology has a 2-year impact factor of 10.092 (2021), article downloads of 431,304 (2021) and 5 days from submission to the first editorial decision (2021).
Nature Portfolio Cancer Community

Discover more about utilizing AI for precision oncology in a Behind the Paper post from Author Istvan Petak

Browse articles

HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patients

Lei Li
Yu Gu
Han Liang
ArticleOpen Access31 May 2023
High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer

Shu-Biao Ye
Yi-Kan Cheng
Ping Lan
ArticleOpen Access31 May 2023
Deep learning generates synthetic cancer histology for explainability and education

James M. Dolezal
Rachelle Wolk
Alexander T. Pearson
ArticleOpen Access29 May 2023
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma

Blessie Elizabeth Nelson
Neha K. Reddy
Vivek Subbiah
Case ReportOpen Access25 May 2023
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127⁺ and KLRG1⁺ CD8 T cells

Zhenzhen Hui
Yulin Ren
Xiubao Ren
ArticleOpen Access25 May 2023
ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma

Sung-Soo Park
Jong Cheol Lee
Jamin Koo
ArticleOpen Access20 May 2023
Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts

C. Sturtzel
S. Grissenberger
M. Distel
ProtocolOpen Access18 May 2023
Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing

Heidi J. Gray
Payel Chatterjee
Carla Grandori
Case ReportOpen Access18 May 2023
A framework for artificial intelligence in cancer research and precision oncology

Raquel Perez-Lopez
Jorge S. Reis-Filho
Jakob Nikolas Kather
EditorialOpen Access17 May 2023

Editorial policies

For Authors and Referees

Trending - Altmetric

Jobs

Postdoctoral Fellow - The Laboratory of Prof. Naoto Hirano

The long-term objective of the Centre for Oncology and Immunology is to identify druggable cancer targets of recalcitrant malignancies and developi...

Hong Kong (HK)

Centre for Oncology and Immunology
Postdoc in Machine Learning for Cancer Pharmacogenomics

APPLICATION CLOSING DATE: July 3rd, 2023 Human Technopole (HT) is a new interdisciplinary life science research institute, created and supported by...

Milan (IT)

Human Technopole
Associate or Senior Editor, NPJ Series (Health/Life Sciences)

Nature Portfolio is a flagship portfolio of journals, products and services including Nature and the Nature-branded journals, dedicated to serving ...

New York City, New York (US)

Springer Nature Group
Postdoctoral Fellow - The Laboratory of Prof. Tracy McGaha

The long-term objective of the Centre for Oncology and Immunology is to identify druggable cancer targets of recalcitrant malignancies and developi...

Hong Kong (HK)

Centre for Oncology and Immunology
Professorship for Experimental Oncology (W3)

The Jena University Hospital (JUH) invites applications for a Professorship for Experimental Oncology (W3) to be filled at the earliest possible da...

07743, Zentrum (DE)

Friedrich-Schiller-Universität Jena

Advertisement

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

Search

Advanced search

Quick links